GB683523A - The manufacture of purine derivatives - Google Patents
The manufacture of purine derivativesInfo
- Publication number
- GB683523A GB683523A GB2183448A GB2183448A GB683523A GB 683523 A GB683523 A GB 683523A GB 2183448 A GB2183448 A GB 2183448A GB 2183448 A GB2183448 A GB 2183448A GB 683523 A GB683523 A GB 683523A
- Authority
- GB
- United Kingdom
- Prior art keywords
- carbethoxy
- yields
- naoh
- amino
- hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 title 1
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 title 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 30
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 7
- 150000001875 compounds Chemical class 0.000 abstract 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 6
- LGDSHSYDSCRFAB-UHFFFAOYSA-N Methyl isothiocyanate Chemical compound CN=C=S LGDSHSYDSCRFAB-UHFFFAOYSA-N 0.000 abstract 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 6
- 230000020477 pH reduction Effects 0.000 abstract 6
- JYGRVMQGWVVHJE-UHFFFAOYSA-N ethyl 2-amino-2-cyanoacetate Chemical compound CCOC(=O)C(N)C#N JYGRVMQGWVVHJE-UHFFFAOYSA-N 0.000 abstract 5
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Substances ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 3
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 abstract 3
- -1 methylureido Chemical class 0.000 abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 229910001854 alkali hydroxide Inorganic materials 0.000 abstract 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 abstract 2
- 238000009835 boiling Methods 0.000 abstract 2
- 239000004202 carbamide Substances 0.000 abstract 2
- LBAQSKZHMLAFHH-UHFFFAOYSA-N ethoxyethane;hydron;chloride Chemical compound Cl.CCOCC LBAQSKZHMLAFHH-UHFFFAOYSA-N 0.000 abstract 2
- QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 abstract 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 abstract 2
- 238000010792 warming Methods 0.000 abstract 2
- UOOOWRVLSKCKGJ-UHFFFAOYSA-N 1-methyl-8-phenyl-3,7-dihydropurine-2,6-dione Chemical compound N1C=2C(=O)N(C)C(=O)NC=2N=C1C1=CC=CC=C1 UOOOWRVLSKCKGJ-UHFFFAOYSA-N 0.000 abstract 1
- AZRCUQFMHMIBDF-UHFFFAOYSA-N 8-benzyl-1-phenyl-3,7-dihydropurine-2,6-dione Chemical compound C(C1=CC=CC=C1)C1=NC=2NC(N(C(C2N1)=O)C1=CC=CC=C1)=O AZRCUQFMHMIBDF-UHFFFAOYSA-N 0.000 abstract 1
- DYSFXFYVBMNZDL-UHFFFAOYSA-N CCO.C=[N+]=[N-] Chemical compound CCO.C=[N+]=[N-] DYSFXFYVBMNZDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 abstract 1
- 229920001807 Urea-formaldehyde Polymers 0.000 abstract 1
- VITFJKNVGRZRKB-UHFFFAOYSA-N acetyl isothiocyanate Chemical compound CC(=O)N=C=S VITFJKNVGRZRKB-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001409 amidines Chemical class 0.000 abstract 1
- NMVVJCLUYUWBSZ-UHFFFAOYSA-N aminomethylideneazanium;chloride Chemical compound Cl.NC=N NMVVJCLUYUWBSZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 150000007529 inorganic bases Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000012948 isocyanate Substances 0.000 abstract 1
- 150000002513 isocyanates Chemical class 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 150000002540 isothiocyanates Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical compound O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 abstract 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 abstract 1
- 229940117953 phenylisothiocyanate Drugs 0.000 abstract 1
- 150000003212 purines Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/22—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Purine compounds of formula (I) or (II) <FORM:0683523/IV (b)/1> <FORM:0683523/IV (b)/2> are made by reacting compounds of formula (III) or (IV) <FORM:0683523/IV (b)/3> <FORM:0683523/IV (b)/4> with an organic or inorganic basic medium preferably pyridine or an alkali hydroxide. When inorganic bases e.g. alkali hydroxides are used, subsequent acidification is necessary. Compounds (III) and (IV) are made by reacting compounds of formula (V) or (VI) <FORM:0683523/IV (b)/5> <FORM:0683523/IV (b)/6> with an isocyanate, an isothiocyanate, a urea, a thiourea or N-substituted derivative thereof, using, for example, a basic medium such as pyridine. Compounds (V) or (VI) are made by condensing compounds of formula <FORM:0683523/IV (b)/7> <FORM:0683523/IV (b)/8> with an iminoether, a thioiminoether or an amidine such as compounds of formula <FORM:0683523/IV (b)/9> <FORM:0683523/IV (b)/100> <FORM:0683523/IV (b)/111> <FORM:0683523/IV (b)/122> <FORM:0683523/IV (b)/133> In the above formul R1, R2, R3 and R4 may be the same or different and represent H, alkyl, aryl or aralkyl groups which may contain inert substituents, X may be O or S and R is H or preferably hydrocarbon such as ethyl. When R3 is H (i) and (ii) are tautomers and when R1 and R4 are H further tautomers of (i) and (ii) may be obtained. In examples: (1) ethyl aminocyanacetate is refluxed in alcoholic-chloroform solution with formamidine hydrochloride to yield 4-amino-5-carbethoxy-iminazole which is refluxed in pyridine with methyl isothiocyanate to give 4-N1-methylthioureido-5-carbethoxy-iminazole which on dissolving in 2N NaOH and acidifying with acetic acid gives 2-thio-1-methylxanthine which may also be made without isolation of the intermediates; (2) ethyl aminocyanacetate refluxed in CHCl3 with thioacetiminobenzyl ether hydrochloride yields 4-amino-5-carbethoxy-2-methyliminazole hydrochloride which is converted by the method of (i) to 4-N1-methyl-thiomido-5-carbethoxy-2-methyliminazole and to 2-thio-1 : 8-dimethylxanthine; (3) 4-amino-5-carbethoxy-2-methyliminazole is refluxed in pyridine with methyl isocyanate, dissolved in hot 10 per cent NaOH after removal of the pyridine, and acidified with acetic acid to give 1 : 8-dimethylxanthine; (4) ethyl aminocyanacetate and thiobenziminobenzyl ether hydrochloride yield 4-amino-5-carbethoxy - 2 - phenyliminazole hydrochloride which with methyl isothiocyanate gives 4-N1-methylthioureido-5-carbethoxy-2-phenyliminazole converted by dissolution in 2N NaOH and acidification to 2 - thio - 8 - phenyl - 1 - methylxanthine; (5) 4-amino-5-carbethoxy-2-phenyliminazole with methylisocyanate yields the corresponding methylureido derivative which on warming with 2N NaOH and acidification yields 1-methyl-8-phenylxanthine; (6) the iminazole of (5) with urea forms 4-ureido-5-carbethoxy-2-phenyliminazole which on treatment with 5 per cent NaOH at 80 DEG C. and subsequent acidification yields 2 : 6-dihydroxy-8-phenylpurine; (7) 4 - amino - 5 - carbethoxy-1-methyl-2-phenyliminazole is refluxed with urea in pyridine and the solid obtained on pouring into water dissolved in 2N NaOH at 80 DEG C. when on acidification 2 : 4-dihydroxy-9-methyl-8-phenylpurine is obtained; (8) the iminazole of (5) and acetylisothiocyanate yields an acetythioureido compound which is hydrolysed with 2N HCl in ethanol to the thioureidoiminazole which on warming in 2N NaOH and acidifying yields 2 - thio - 8 - phenylxanthine; (9) ethyl aminocyanacetate with phenylacetiminoethylthioether hydrochloride yields 4-amino-5-carbethoxy-2-benzyliminazole hydrochloride which with phenylisocyanate gives 4 - N1 - phenylureido - 5 - carbethoxy - 2 - benzyliminazole converted to 8-benzyl-1-phenyl-xanthine on boiling in 2N NaOH and acidifying; (10) 4-amino-5-carbethoxy-2-benzyliminazole with phenylisothiocyanate yields a phenylthioureido compound which with 2N NaOH at 90 DEG C. and acidification yields 2-thio-1-phenyl-8-benzylxanthine; (11) the same benzyliminazole is methylated either with diazomethane in methanol or dimethyl sulphate and refluxed with pyridine and methyl isothiocyanate to give a methylthioureido compound which is converted to 2-thio-1 : 7-dimethyl-8-benzylxanthine; (12) the iminazole of (5) is methylated with ethanol diazomethane to the 2-phenyl-1-methyliminazole which is converted to 4-N1-methylthioureido-5-carbethoxy-2-phenyl-1-methyl-imina zole and then to 2-thio-8-phenyl-1 : 7-dimethylxanthine as in (1); (13) ethyl aminocyanacetate with p - nitrophenylacetiminobenzylthioether hydrochloride gives 4-amino-5-carbethoxy-2-(p1-nitrobenzyl)-iminazole hydrochloride which with methylisocyanate yields 4-N1-methylureido-5-carbethoxy-2-(p1-nitrobenzyl) -iminazole converted to 8-(p1-nitrobenzyl)-1-methylxantine on boiling with 5 per cent NaOH and acidifying. Specifications 683,593 and 683,594 are referred to.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2183448A GB683523A (en) | 1948-08-18 | 1948-08-18 | The manufacture of purine derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2183448A GB683523A (en) | 1948-08-18 | 1948-08-18 | The manufacture of purine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB683523A true GB683523A (en) | 1952-12-03 |
Family
ID=10169590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2183448A Expired GB683523A (en) | 1948-08-18 | 1948-08-18 | The manufacture of purine derivatives |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB683523A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4325956A (en) | 1978-10-20 | 1982-04-20 | Aktiebolaget Draco | Method and pharmaceutical preparation for treating chronic obstructive airway disease and cardiac disease, and intermediates for the preparation of therapeutically active xanthine derivatives |
| US4338319A (en) | 1979-11-27 | 1982-07-06 | Aktiebolaget Draco | Method for the treatment of chronic obstructive airway or cardiac diseases |
| US4548818A (en) * | 1978-10-20 | 1985-10-22 | Kjellin Per G | Composition and methods for the treatment of chronic obstructive airway disease and cardiac disease using 3-alkylxanthines |
| WO2010103547A3 (en) * | 2009-03-13 | 2010-12-02 | Advinus Therapeutics Private Limited | Substituted fused pyrimidine compounds |
-
1948
- 1948-08-18 GB GB2183448A patent/GB683523A/en not_active Expired
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4325956A (en) | 1978-10-20 | 1982-04-20 | Aktiebolaget Draco | Method and pharmaceutical preparation for treating chronic obstructive airway disease and cardiac disease, and intermediates for the preparation of therapeutically active xanthine derivatives |
| US4548818A (en) * | 1978-10-20 | 1985-10-22 | Kjellin Per G | Composition and methods for the treatment of chronic obstructive airway disease and cardiac disease using 3-alkylxanthines |
| US4644001A (en) * | 1978-10-20 | 1987-02-17 | Aktiebolaget Draco | 3-Alkylxanthines, composition and methods for the treatment of chronic obstructive-airway disease and cardiac disease |
| US4338319A (en) | 1979-11-27 | 1982-07-06 | Aktiebolaget Draco | Method for the treatment of chronic obstructive airway or cardiac diseases |
| WO2010103547A3 (en) * | 2009-03-13 | 2010-12-02 | Advinus Therapeutics Private Limited | Substituted fused pyrimidine compounds |
| AU2010222289B2 (en) * | 2009-03-13 | 2013-07-11 | Advinus Therapeutics Private Limited | Substituted fused pyrimidine compounds |
| US8859566B2 (en) | 2009-03-13 | 2014-10-14 | Advinus Therapeutics Private Limited | Substituted fused pyrimidine compounds |
| US9284316B2 (en) | 2009-03-13 | 2016-03-15 | Advinus Therapeutics Private Limited | Substituted fused pyrimidine compounds |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1190224A (en) | Derivatives of 1,2-diamino-cyclobutene-3,4-dione as potent histamine h.sub.2-antagonists | |
| US2485212A (en) | 2-[phenthiazinyl-(n)-methyl]-imidazolines, the corresponding 2-(phenoxazinyl) imidazolines, and their salts | |
| CA2063172A1 (en) | 4-aryl-thiazole or imidazole derivatives | |
| JPS5817454B2 (en) | Alkylated hydroxylamine and its production method | |
| SU557758A3 (en) | Method for preparing 4-azabenzimidazoles or their salts | |
| GB683523A (en) | The manufacture of purine derivatives | |
| US4324899A (en) | 2-Amino-5-cyanothiazoles and their preparation | |
| SU513624A3 (en) | Method for preparing 2-piperazinyl thiazole derivatives | |
| SU580836A3 (en) | Method of preparing 4-oxybenzimidazole base-substituted derivatives or salts thereof | |
| US4477661A (en) | Process for the preparation of 4-hydroxy-3-(heterocyclocarbamoyl)-2H-1,2-benzothiazine-1,1-dioxides | |
| US3341536A (en) | 2-morpholino, or piperidino alkyl sulfinyl or sulfonyl-pyridines and halo pyridines | |
| US3818023A (en) | 2-phenyl benzothiazolyl acetic acid derivatives | |
| US2527265A (en) | Thiazolidone compounds | |
| US2530570A (en) | Pyrimidylmercapto-carboxylic acids | |
| US3483212A (en) | 5-nitroimidazoles | |
| US3370064A (en) | Certain 4-(chlorophenylhydrazono)-2-isoxazolin-5-ones | |
| US4845122A (en) | Anti-allergy treatment using 2-(substituted amino)-4,5-dihydro-4-oxo-3-furancarboxylic acids and derivatives thereof | |
| MISANI et al. | The search for superior drugs for tropical diseases. III. Further experiments in the quinoline group | |
| US2652401A (en) | Benzothiazole derivatives and method of production | |
| US2524800A (en) | Hydroxybenzenesulfonamidoheterocycles and preparation of same | |
| IE913777A1 (en) | Novel compounds, pharmaceutical compositions containing them¹and process for preparing same | |
| Reeve et al. | Reaction of cyanamide with aryl (trichloromethyl) carbinols. Novel synthesis of alkyl 5-aryl-2-imino-4-oxo-1-imidazolidinecarboximidates | |
| Knott | 118. Polycyclic thiazoles | |
| CA1050544A (en) | Process for the preparation of 2-acylamino-benzylamines | |
| US2820793A (en) | 5-nitrosimino-4-substituted-delta2-1,3,4-thiadiazoline-2-sulfonamides |